{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:57Z","timestamp":1786119657332,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/aog.0b013e31818d8eb4","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:34:47Z","timestamp":1291102487000},"page":"1303-1310","source":"Crossref","is-referenced-by-count":84,"title":["Two Distinct Oral Routes of Misoprostol in Mifepristone Medical Abortion"],"prefix":"10.1097","volume":"112","author":[{"given":"Beverly","family":"Winikoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana G.","family":"Dzuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Crowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Prine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin S.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210126","first-page":"871","article-title":"ACOG practice bulletin. Clinical management guidelines of obstetrician-gynecologists. Number 67, October 2005. Medical management of abortion.","volume":"106","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R2-18-20210126","article-title":"NAF protocol for mifepristone\/misoprostol in early abortion.","year":"2006"},{"key":"R3-18-20210126","article-title":"The care of women requesting induced abortion. Evidence-based Clinical Guideline No. 7.","year":"2004"},{"key":"R4-18-20210126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2005.02.019","article-title":"Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.","volume":"123","author":"Arvidsson","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R5-18-20210126","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/humrep\/17.3.654","article-title":"Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability.","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"R6-18-20210126","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMoa051620","article-title":"Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion.","volume":"353","author":"Fischer","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-18-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.AOG.0000287291.19230.ba","article-title":"Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion.","volume":"110","author":"Cohen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R8-18-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion.","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"R9-18-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral vs vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy [published erratum appears in Contraception 2002;66:481].","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"R10-18-20210126","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-0528.2003.02430.x","article-title":"WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy.","volume":"110","author":"von Hertzen","year":"2003","journal-title":"BJOG"},{"key":"R11-18-20210126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2005.05.017","article-title":"Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.","volume":"72","author":"Middleton","year":"2005","journal-title":"Contraception"},{"key":"R12-18-20210126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration.","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"R13-18-20210126","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response.","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R14-18-20210126","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials.","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"R15-18-20210126","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials.","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"key":"R16-18-20210126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-0528.2006.00948.x","article-title":"Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.","volume":"113","author":"Shannon","year":"2006","journal-title":"BJOG"},{"key":"R17-18-20210126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.","volume":"107","year":"2000","journal-title":"BJOG"},{"key":"R18-18-20210126","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(00)03549-2","article-title":"Mifepristone abortion outside the urban research hospital setting in India.","volume":"357","author":"Coyaji","year":"2001","journal-title":"Lancet"},{"key":"R19-18-20210126","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/oxfordjournals.humrep.a138287","article-title":"The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol.","volume":"8","author":"McKinley","year":"1993","journal-title":"Hum Reprod"},{"key":"R20-18-20210126","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/HUMREP\/10.6.1521","article-title":"Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.","volume":"10","author":"Baird","year":"1995","journal-title":"Hum Reprod"},{"key":"R21-18-20210126","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States.","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"R22-18-20210126","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/deg475","article-title":"A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.","volume":"18","author":"Tang","year":"2003","journal-title":"Hum Reprod"},{"key":"R23-18-20210126","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-0528.2005.00638.x","article-title":"A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.","volume":"112","author":"Hamoda","year":"2005","journal-title":"BJOG"},{"key":"R24-18-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2007.05.088","article-title":"Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study.","volume":"76","author":"Lohr","year":"2007","journal-title":"Contraception"},{"key":"R25-18-20210126","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2004.05.003","article-title":"Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.","volume":"70","author":"Wiebe","year":"2004","journal-title":"Contraception"},{"key":"R26-18-20210126","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM199504133321502","article-title":"Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.","volume":"332","author":"el-Refaey","year":"1995","journal-title":"N Engl J Med"},{"key":"R27-18-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.contraception.2003.11.010","article-title":"Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion.","volume":"69","author":"Hedley","year":"2004","journal-title":"Contraception"},{"issue":"suppl","key":"R28-18-20210126","first-page":"173","article-title":"Instituting medical abortion services: changes in outcome and acceptability related to provider experience.","volume":"55","author":"Borgatta","year":"2000","journal-title":"J Am Med Womens Assoc"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200812000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:53Z","timestamp":1786041953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200812000-00018"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e31818d8eb4","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}